Turkish Pharmaceutical Market

Ranked as the 16th largest pharmaceutical market in the world, the Turkish pharmaceutical market offers many opportunities. However, there are many challenges that pharmaceutical companies have to overcome in the country, including the complex regulatory and pricing process, as well as the mandatory discounts imposed on pharmaceutical products in order to gain inclusion on Turkey’s drug reimbursement list.

Highlights in this white paper include:

Advantages in the Turkish pharmaceutical market.
Exploration into the drug approval delay in Turkey.
Discussion into reference pricing, statutory discounts and the Turkish lira/euro exchange rate.